Results 131 to 140 of about 30,607 (232)

Clinical Versus Pathologic Staging in Early‐Stage Non‐Small Cell Lung Cancer Assessed by an Established Lung Cancer Multidisciplinary Meeting

open access: yesThoracic Cancer, Volume 17, Issue 6, March 2026.
Clinical and pathological staging concordance in early‐stage NSCLC occurred in 73% of cases. Clinical under‐staging occurred in 18.9% of cases. Under‐staging was associated with treatment delays and tumor histopathology and increased the risk of disease recurrence and mortality.
James Nolan   +3 more
wiley   +1 more source

Effect of adding indocyanine green to identifying sentinel lymph node in breast cancer patients after neoadjuvant chemotherapy. [PDF]

open access: yesRev Assoc Med Bras (1992)
Akçakoca G   +7 more
europepmc   +1 more source

Enumeration, Phenotyping, and Clinical Associations of Tissue‐Resident T Cells in the Ecto‐ and Endocervix of Women Attending a Colposcopy Clinic

open access: yesAmerican Journal of Reproductive Immunology, Volume 95, Issue 3, March 2026.
ABSTRACT Problem Tissue‐resident memory (TRM) cells represent important immune sentinels that mount rapid recall responses to pathogens and cancers. However, there are limited data in humans on genital tract TRM collected by clinically feasible sampling methods, limiting a full understanding of their role in immunity and clinical disease.
Aloysious Ssemaganda   +17 more
wiley   +1 more source

The Breast Cancer Treatment Experience for a Breast Cancer Patient Living With Intellectual or Developmental Disabilities in Ontario, Canada: A Critical Realist Case Study

open access: yesBritish Journal of Learning Disabilities, Volume 54, Issue 1, Page 3-14, March 2026.
ABSTRACT Background Adult females with intellectual or developmental disabilities are more likely to die following a breast cancer diagnosis. Differences in access to cancer treatment may contribute to these survival differences. We explored how one woman with intellectual or developmental disabilities received guideline‐recommended breast cancer ...
Rebecca Hansford   +3 more
wiley   +1 more source

FDG and FAPI PET–based response evaluation to reduced‐dose nivolumab in pleural mesothelioma: A case report

open access: yesClinical Physiology and Functional Imaging, Volume 46, Issue 2, March 2026.
Abstract Reliable tools for objective response assessment are essential in pleural mesothelioma treated with immunotherapy. We report on a 75‐year‐old man with sarcomatoid pleural mesothelioma who received a reduced nivolumab dose after developing a hypersensitivity reaction during the first infusion.
Morten Bentestuen   +5 more
wiley   +1 more source

Deep Dermal and Subcutaneous Deposits in Thin Melanoma: A Cautionary Tale

open access: yesJournal of Cutaneous Pathology, Volume 53, Issue 3, Page 224-229, March 2026.
ABSTRACT Melanoma microsatellites are peritumoral metastatic deposits and surrogates for potentially aggressive biological behavior. Their presence indicates clinical stage III disease. They are rarely reported in association with thin primary tumors (< 1.0 mm, pT1).
Angela Cheng   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy